| DEVELOPMENT | Co.'s scientists have been working for close to 10 years on a new route to corticosteroids, a class of compounds that are a legacy of Roussel Uclaf but are now only a minor part of Co.'s consumer drug business. Now, Co. is getting close to a third route, based totally on fermentation, that promises to be inexpensive and free of raw material constraints |
| UPDATE | 12.02 |
| COMPANY | This data is not available for free |
| LITERATURE REF. | This data is not available for free |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |